Previous 10 | Next 10 |
home / stock / ipsey / ipsey news
Ipsen S.A. ( OTCPK:IPSEY ) Q1 results ((€)): More news on: Ipsen S.A., Ipsen S.A., Healthcare stocks news, Earnings news and commentary, , Read more ...
Continued momentum with Q1 2020 Group sales growth of 9.6% as reported, or 8.7% 1 at constant exchange rates Limited Q1 2020 financial impact from COVID-19 given resilient Specialty Care product portfolio comprised mostly of highly-differentiated treatments for critical conditio...
Study met primary endpoint of significantly improving progression-free survival, and secondary endpoints of overall survival and objective response rate vs. sunitinib CABOMETYX in combination with Opdivo demonstrates clinically meaningful efficacy results across all endpoints and...
Quick Take Lantern Pharma ( LTRN ) has filed to raise $28.75 million in an IPO of its common stock, according to an S-1 registration statement . The firm is developing a pipeline of drug candidates for the treatment of prostate, lung and other cancers. LTRN seeks to use its proprietary ...
Regulatory News: The biopharmaceutical group Ipsen has answered call of the Institut Pasteur and announces today a donation of €2 million dedicated to COVID-19 research. Since January, the Institut Pasteur has devoted a portion of its research to understanding the emerging COVID-1...
Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing Canada NewsWire NEW YORK, March 26, 2020 NEW YORK , March 26, 2020 /CNW/ - Deutsche Bank today announced that the presentations from the March 18 th and 19...
NEW YORK , March 26, 2020 /PRNewswire/ -- Deutsche Bank today announced that the presentations from the March 18 th and 19 th Depositary Receipts Virtual Investor Conference ("dbVIC") are now available for on-demand viewing. The event featured presentations from international companie...
Ipsen to reinitiate palovarotene dosing in patients 14 years of age and older with fibrodysplasia ossificans progressiva Ipsen to terminate MO-Ped trial (PVO-2A-201) in patients with multiple osteochondromas to analyze accumulated data and assess the future of palovarotene in this indi...
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) provided today an update related to the impact of the Covid-19 pandemic on its global business which is affected in varying degrees in the countries impacted by the coronavirus, with very different and evolving situations from one country...
New York City, NY: March 16, 2020 - Published via (Wired Release) - Recent Research and Future Market Potential of Gas Nitriding Furnace Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and info...
News, Short Squeeze, Breakout and More Instantly...
Ipsen SA ADR Company Name:
IPSEY Stock Symbol:
OTCMKTS Market:
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases Canada NewsWire Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaboration Following development ...
Marengo Therapeutics Announces First Drug Candidate Nomination from Oncology Collaboration with Ipsen PR Newswire A Novel TCR Vβ bifunctional selective T cell activator molecule for solid tumor treatment Marengo to receive an associated milestone payment a...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...